Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

The missing middle in cutaneous lupus: When should comorbidity screening begin?

AI Summary
  • Comorbidity screening should start early, ideally at cutaneous lupus diagnosis, to detect systemic progression and cardiometabolic risk.
  • Cardiovascular disease, metabolic syndrome and concurrent autoimmune conditions are common and require proactive monitoring and management.
  • Employ risk stratification, patient education and multidisciplinary care to tailor screening frequency and interventions according to severity and systemic features.
Summarise with AI (MRCPsych/FRANZCP)

J Eur Acad Dermatol Venereol. 2026 Jul 14. doi: 10.1111/jdv.70620. Online ahead of print.

NO ABSTRACT

PMID:42447180 | DOI:10.1111/jdv.70620

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD